Boston Scientific Corp. (NYSE: BSX) is buying Bard EP, the electrophysiology business of C.R. Bard, for $275 million in cash.

Lowell, Mass.-based Bard EP provides cardiac catheter and recording device technologies. The company will become part of Boston Scientific’s existing electrophysiology business.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.